Search Results 311-320 of 17407 for Bronchodilators

  1. Extracorporeal membrane oxygenation (ECMO) - Doctors & Departments - Mayo Clinic

    Mayo Clinic surgeons are among the world's most experienced. They performed some of the world's first open heart surgeries in children using a heart-lung ...

  2. Pulmonary Medicine Clinical Trials - Medical Professionals

    The purpose of this study is to ensure technical success in the treatment of assessing diaphragmatic neuromuscular junction (NMJ) function of the diaphragm in ...

  3. Cough Reflex Sensitivity and Bronchial Hyper-responsiveness - Mayo Clinic

    The aim of this study is to provide pilot data on the possible gastrointestinal predictors of respiratory hyper-responsiveness and how these relate to the ...

  4. Respiratory Syncytial Virus Disease in Adults with High-Risk Conditions in North American Communities - Mayo Clinic

    The primary purpose of this study is to estimate the incidence rate of confirmed respiratory syncytial virus (RSV) (and other confirmed respiratory viruses) ...

  5. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  6. A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough - Mayo Clinic

    Pre-bronchodilator FEV1/FVC <60% at screening or on spirometry testing performed within the 2 years before screening and following the onset of chronic cough.

  7. Candesartan and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure reduces the ...

  8. Mayo Clinic

    Share · Tweet . VID-20427263. Home; Celebration of Life Spring 2018. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...

  9. A Study to Evaluate Plasma and Sputum As Noninvasive Biomarkers for Bronchial Dysplasia Progression/Regression - Mayo Clinic

    This study is designed to determine whether or not plasma and sputum microRNA might be an effective, non-invasive biomarker for lung cancer risk. More ...

  10. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

    A pre- or post-bronchodilator FEV1 of 1.0 L and > 40% postoperative predicted value and DLCO > 40% predicted value are required prior to enrollment. The ...